Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: Clinical and prognostic significance

Cancer Science

Volumn 101, Issue 6, 2010, Pages 1511-1520

  Ghosh, Amlan ^a   Ghosh, Susmita ^a   Maiti, Guru Prasad ^a   Sabbir, Mohammad Golam ^a   Zabarovsky, Eugene R ^b   Roy, Anup ^c   Roychoudhury, Susanta ^d   Panda, Chinmay Kumar ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

^d INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN MLH1;

ADULT; APRG1 TUMOR SUPPRESSOR GENE; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CANCER TISSUE; CHROMOSOME 3P; CONTROLLED STUDY; DYSPLASIA; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITGA9 TUMOR SUPPRESSOR GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN METHYLATION; RBSP3 TUMOR SUPPRESSOR GENE; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VERRUCA VULGARIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRINS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 77954145997     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01551.x     Document Type: Article

References (23)

1. Tripathi A, Dasgupta S, Roy A. Sequential deletions in both arms of chromosome 9 are associated with the development of head and neck squamous cell carcinoma in Indian patients. J Exp Clin Cancer Res 2003, 22:289-97.
2. Ordonez BP, Beauchemin M, Jordan RCK. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006, 59:445-53.
3. Kim MM, Califano JA. Molecular pathology of head and neck cancer. Int J Cancer 2004, 112:545-53.
4. Uzawa N, Yoshida MA, Oshimaura M, Ikeuchi T. Suppression of tumorigenicity in three different cell lines of human oral squamous cell carcinoma by introduction of chromosome 3p via microcell mediated chromosome transfer. Oncogene 1995, 11:1997-2004.
5. Chakraborty SB, Dasgupta S, Roy A. Differential deletions in 3p are associated with the development of head and neck squamous cell carcinoma from Indian patients. Cancer Genet Cytogenet 2003, 145:1-9.
6. Papadopoulos N, Nicolaides NC, Wei Y-F. Mutation of a mutL homolog in hereditary colon cancer. Science 1994, 263:1625-9.
7. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in HNSCC tumors and leukoplakia samples by promoter hypermethylation and its relation with MIN phenotype. Cancer 2007, 109(4):703-12.
8. Sinha S, Singh RK, Alam N, Roy A, Roychoudhury S, Panda CK. Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset reast carcinoma: clinical and prognostic significance. Cancer Sci 2008, 99(10):1984-91.
9. Leung SY, Yuen ST, Chung LP, Chu KM, Chan ASY, Ho JCI. hMLH1 Promoter Methylation and Lack of hMLH1 Expression in Sporadic Gastric Carcinomas with High-Frequency Microsatellite Instability1. Cancer Res 1999, 59:159-64.
10. Protopopov A, Kashuba V, Zabarovska VI. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res 2003, 63:404-12.
11. Singh P, Chen C, Ghosh SP, Stepp MA, Sheppard D, Water LVD. Loss of Integrin α9β1 Results in Defects in Proliferation, Causing Poor Re-Epithelialization during Cutaneous Wound Healing. J Invest Dermatol 2009, 129:217-28.
12. Grassinger J, Haylock DN, Storan MJ. Thrombin cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood 2009, 114(1):49-59.
13. Young BA, Taooka Y, Liu S. The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillinin-independent Manner. Mol Biol Cell 2001, 12:3214-25.
14. Hakkinen L, Kainilainen T, Salo T, Grenman R, Larjava H. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis 1999, 5:210-7.
15. Kashuba VI, Li J, Wang F. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci U S A 2004, 101:4906-11.
16. Loginov VI, Malyukova AV, Seryogin YA. Methylation of the promoter region of the RASSF1A candidate tumor suppressor gene in primary epithelial tumors. Mol Biol 2004, 38:654-67.
17. Dallol A, Da Silva NF, Viacava P. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast Cancers. Cancer Res 2002, 62:5874-80.
18. Weinberger PM, Yu Z, Haffty BJ. Molecular classification identifies subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006, 24:736-47.
19. Ghosh A, Ghosh S, Maity GP. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. J Pathol 2009, 217:408-19.
20. Zhang H, Sheng JQ, Geng HG, Han Y, Li SR, Li AQ. Detection of large intragenic mismatch repair genes deletions in Chinese hereditary nonpolyposis colorectal cancer families with multiplex ligation-dependent probe amplification technique. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006, 28(6):837-9.
21. Wheeler JMD, Loukola A, Aaltonen LA, Mortensen NJ, Bodmer WF. The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers. J Med Genet 2000, 37:588-92.
22. Shu J, Jelinek J, Chang H. Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Cancer Res 2006, 66:5077-84.
23. Brigitta MN. Brinkman. Splice variants as cancer biomarkers. Clin Biochem 2004, 37:584-94.